Drug Screening Market Share

  • Report ID: 4891
  • Published Date: Oct 14, 2024
  • Report Format: PDF, PPT

Drug Screening Market Share

North American Market Forecast

The drug screening market in the North America region, will hold the largest market share of nearly 35% in the upcoming years. The increasing number of accidents owing to drug impairment in the region is surging the requirement for drug screening in the North America region. As per a recent survey in the United States in 2022, more than 50 percent of people killed or injured in traffic crashes had alcohol or drugs in their bloodstream. The drug screening industry in the region has witnessed significant technological advancements in recent years, resulting in improved accuracy and sensitivity of drug screening tests. This has made drug screening a more reliable and effective option for various industries in the North American region. Furthermore, there has been increasing government funding in the region in order to limit drug abuse.

APAC Market Statistics

The drug screening market in the Asia Pacific region, is predicted to hold the 2nd largest share of close to 24% till 2037. Regional growth can be impelled by the rising awareness about drug screening. This has led to an increase in demand for drug screening services, including rapid testing devices. Governments in the Asia Pacific region are taking steps to combat drug abuse by implementing drug screening programs in different sector. For instance, in 2019, the Malaysian government announced that it would introduce mandatory drug screening for all foreign workers. Similarly, the Indian government has launched a national program to conduct drug screening tests for truck drivers.

Research Nester
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4891
  • Published Date: Oct 14, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of drug screening is estimated at USD 11.57 billion.

The drug screening market size was over USD 9.99 billion in 2024 and is projected to cross USD 105.01 billion by the end of 2037, growing at more than 19.6% CAGR during the forecast period i.e., between 2025-2037. Increasing prevalence of drug abuse, and stringent government regulations will boost the market growth.

Asia Pacific industry is set to hold 24% of the revenue share till 2037, impelled by rising awareness about drug screening in the region.

The major players in the market include Quest Diagnostics, Laboratory Corporation of America Holdings (LabCorp), Thermo Fisher Scientific, Alere Inc., Siemens Healthineers, Shimadzu Corporation, F. Hoffmann-La Roche AG, Express Diagnostics International Inc., OraSure Technologies, Drägerwerk AG & Co. KGaA.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample